Welcome to our dedicated page for LINDE PLC SEC filings (Ticker: LIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Linde plc filings document an Irish public company's industrial gases and engineering business, Nasdaq-listed ordinary shares, operating results and capital-structure activity. Results 8-Ks furnish quarterly and annual financial releases covering sales, operating profit, cash flow, capital expenditures, dividends and stock repurchases for a business serving chemicals and energy, food and beverage, electronics, healthcare, manufacturing, metals and mining.
Governance filings include definitive proxy materials, annual general meeting voting results, board elections, executive compensation and leadership changes. Other 8-K disclosures record euro note issuances under Linde's European debt issuance programme and related use of proceeds for general corporate purposes.
A holder of common stock of the issuer of LIN has filed a notice of proposed sale of 9,455 common shares. The shares have an aggregate market value of 4,542,654.75 and are to be sold on NASDAQ through Fidelity Brokerage Services LLC, with an approximate sale date of 02/17/2026. The seller acquired these shares on 02/17/2026 by a stock option exercise, paying the purchase price in cash. The filing notes that shares outstanding were 466,948,930 at the time of this notice.
A holder of LIN common stock has filed a notice of proposed sale under Rule 144 for 75,607 shares, with an aggregate market value of $36,119,599.28. The filing notes that 466,948,930 shares of this class are outstanding.
The shares to be sold were acquired on 02/13/2026 through the cash exercise of stock options originally granted on 02/28/2017 for 30,165 shares and on 02/27/2018 for 45,442 shares. The planned sale is to be executed through Fidelity Brokerage Services LLC on or around 02/13/2026 on the NASDAQ market.
Linde plc filed a current report to share that it has released its financial results for the quarter and year ended December 31, 2025. The company furnished a press release, dated February 5, 2026, as Exhibit 99.1, which contains the detailed results of operations and financial condition.
The report treats the press release as part of its disclosure by incorporating it by reference into the section covering results of operations and financial condition.
Linde plc director Stephen F. Angel reported a compensation-related share transaction. On January 20, 2026, 7,248.579 deferred stock units were paid out in Linde ordinary shares at a price of $0 per share under the Linde Compensation Deferral Plan. In connection with this payout, 2,552.269 ordinary shares were withheld at $440.04 per share to cover taxes.
After these transactions, Angel directly owned 460,238.812 Linde ordinary shares. He also reported additional indirect holdings, including 71,029 ordinary shares held through a 2010 Descendants Trust, along with other ordinary shares held in a 2012 Descendants Trust, in trust for children, and in a 401(k) account.
Linde plc reported issuing three euro-denominated note tranches under its European debt issuance programme. The company sold €600 million Floating Rate Notes due 2027, €650 million 3.125% Notes due 2032 and €500 million 3.750% Notes due 2038. Net proceeds were approximately €1,737 million after fees to the managers and will be used for general corporate purposes.
The notes are admitted to the official list of the Luxembourg Stock Exchange and trade on its Euro MTF market. They were issued under Linde’s European debt issuance programme, which permits up to €20 billion aggregate principal amount of notes to be outstanding. Notes issued under the programme are guaranteed by Linde GmbH and Linde Inc. and are offered outside the United States under Regulation S.
Linde plc reported stronger Q3 2025 results. Sales were $8,615 million, up from $8,356 million a year ago. Operating profit rose to $2,367 million from $2,086 million, and net income attributable to Linde increased to $1,929 million. Diluted EPS was $4.09 versus $3.22.
For the first nine months, operating cash flow reached $7,320 million, funding capital expenditures of $3,803 million, share repurchases of $3,205 million, and dividends of $2,113 million. Total debt was $25,925 million at September 30, 2025, up from $21,623 million at year‑end, reflecting new issuances including €850 million 2.625% notes due 2029, €750 million 3.00% notes due 2033, €650 million 3.25% notes due 2037, and CHF225 million 0.6150% notes due 2029 and CHF275 million 1.0629% notes due 2033; Linde also redeemed $600 million 4.700% notes and repaid $400 million 2.65% notes due 2025.
At September 30, 2025, cash and cash equivalents were $4,509 million and 466,948,930 ordinary shares were outstanding. Disclosed contingencies include $1.2 billion related to terminated Russian engineering projects with RCA and $0.7 billion tied to Amur GPP matters; proceedings and arbitrations remain ongoing.
Linde plc furnished an 8-K under Item 2.02 to announce results of operations for the quarter ended September 30, 2025. The company attached a press release dated October 31, 2025 as Exhibit 99.1, which is incorporated by reference.
Linde’s ordinary shares (nominal value €0.001) trade on the Nasdaq Stock Market under the symbol LIN.
Linde plc (LIN) reported an initial statement of beneficial ownership (Form 3) for its SVP, Americas, effective 10/22/2025. The officer holds 12,335.266 ordinary shares directly and 923.986 ordinary shares indirectly via a 401(k).
Reported derivative holdings include Restricted Stock Units for 1,064, 980, and 960 ordinary shares that vest and pay out on or about March 7, 2028, March 7, 2027, and March 7, 2026, respectively, on a one-for-one basis. Stock options are listed across multiple grants, including 7,468 options at an exercise price of $468.77 expiring 03/07/2035, and 6,340 options at $465.29 expiring 03/07/2034, each vesting in three equal annual installments beginning the March following grant. The filing also notes 240.682 deferred stock units payable one-for-one in ordinary shares under the company’s deferral plan.
The form was signed by Anthony M. Pepper as attorney-in-fact.
Linde plc reported upcoming leadership changes at the board and executive levels. Stephen F. Angel, currently Chairman of the Board, announced he will retire from Linde’s Board of Directors effective January 31, 2026. Upon his retirement, CEO Sanjiv Lamba will also become Chairman of the Board, while Robert Wood will continue to serve as Lead Independent Director, preserving an independent leadership role on the board.
Linde also announced that its Board has appointed Sean Durbin, currently Executive Vice President – North America, as Chief Operating Officer effective October 1, 2025, reporting to the CEO. Durbin has held senior roles across North America and EMEA and has been with Praxair and Linde-related businesses since 1993, bringing long operational and regional leadership experience into the new COO position.
Guillermo Bichara, Executive Vice President & Chief Legal Officer of Linde plc (LIN), reported insider transactions dated 09/11/2025. The filing shows a gift disposition of 640 ordinary shares (transaction code G) with $0 received, reducing direct holdings to 22,137.769 ordinary shares. The report also discloses 2,890.178 shares held indirectly in a 401(k) plan. The Form 4 lists outstanding equity awards: restricted stock units totaling 4,863 RSUs scheduled to vest between 2026 and 2028, multiple stock options exercisable through 2035 representing specified share counts, and 794.534 deferred stock units payable one-for-one in ordinary shares under the company deferral plan.